Please use this identifier to cite or link to this item:
https://saber.ucv.ve/jspui/handle/10872/21171Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Ponte-Sucre, Alicia | - |
| dc.date.accessioned | 2021-06-24T20:48:03Z | - |
| dc.date.available | 2021-06-24T20:48:03Z | - |
| dc.date.issued | 2021-06-24 | - |
| dc.identifier.uri | http://hdl.handle.net/10872/21171 | - |
| dc.language.iso | es | en_US |
| dc.subject | Covid-19 | en_US |
| dc.subject | Sars-CoV-2 | en_US |
| dc.subject | farmacopea | en_US |
| dc.title | Avances de la farmacopea contra Covid-19 al 02 de mayo de 2020, breves comentarios | en_US |
| dc.type | Other | en_US |
| Appears in Collections: | Artículos Publicados | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Avances de la farmacopea contra Covid-19 al 02 de mayo de 2020.pdf | 111.5 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.